(9/13) Friday's Pre-Market News & Stock Movers Good Morning StonkForumers! Happy Friday! Stock futures rise after S&P 500 notches fourth-straight winning session: Live updates U.S. stock futures rose Friday as traders sought to shake off a sluggish September. S&P 500 futures climbed about 0.2% and Nasdaq 100 futures hovered above flat. Futures tied to the Dow Jones Industrial Average added 45 points, or 0.1%. The S&P 500 and Nasdaq Composite are coming off their fourth straight winning session, adding to their strong week-to-date performances. The broad market index is up nearly 3.5% this week, while the Nasdaq has popped 5.3%. The Dow has advanced 1.9%. Wall Street is now looking ahead toward the Federal Reserve’s policy meeting on Sept. 17-18, where the central bank is largely anticipated to lower interest rates by 25 basis points. Currently, the Fed’s target rate is sitting at 5.25% to 5.5%. Economic data reflecting a moderation in inflation also seemed to support the case for a rate cut. The consumer price index in August came in at 2.5% on annualized basis, the lowest level since February 2021. Wholesale prices, meanwhile, rose 0.2% in August, coming in line with expectations. “At the end of the day, the U.S. consumer and the economy continue to do well, [and] profits continue to print above expectations,” Dan Greenhaus, chief strategist at Solus Alternative Asset Management, said on CNBC’s “Closing Bell” on Thursday. “And so while we had a meaningful sell-off driven by some of those AI names, for sure, the rebound seems entirely justified because it doesn’t seem like these issues are broadening out,” he added. On the economic front, traders will look toward August’s import prices data Friday morning. Preliminary consumer sentiment figures for September are also scheduled for release. STOCK FUTURES NOW: YESTERDAY'S MARKET HEAT MAP: YESTERDAY'S S&P SECTORS: TODAY'S ECONOMIC CALENDAR: THIS MONTH'S ECONOMIC CALENDAR: MOST ACTIVE TRENDING DISCUSSIONS (STOCK SYMBOLS ARE CLICKABLE!): BA Boeing Co NNE Nano Nuclear Energy Inc. AUPH Aurinia Pharmaceuticals Inc ADBE Adobe Inc CKB.X Nervos Network RH Restoration Hardware ENVX Enovix Corporation TIL Instil Bio Inc ORCL Oracle Corp. MATIC.X Polygon NEXT WEEK'S IPO'S: NEXT WEEK'S EARNINGS CALENDAR: THIS MORNING'S PRE-MARKET EARNINGS RELEASES: BEFORE TODAY'S MARKET OPEN: THIS AFTERNOON'S AFTER-HOURS EARNINGS RELEASES: AFTER TODAY'S MARKET CLOSE: (NONE.) YESTERDAY'S ANALYST UPGRADES/DOWNGRADES: YESTERDAY'S INSIDER TRADING FILINGS: TODAY'S DIVIDEND CALENDAR: (N/A.) THIS MORNING'S PRE-MARKET STOCK NEWS MOVERS: source: cnbc.com Boeing — The stock sank 4% after Boeing factory workers went on strike early Friday after rejecting a new labor contract. The work stoppage will impact production of most aircrafts, including the 737 Max. Oracle — Shares of the database software company rallied more than 6%. Oracle lifted its fiscal 2026 revenue forecast and shared strong guidance for the 2029 fiscal year. Moderna — Shares dropped 4% after JPMorgan downgraded the drugmaker to underweight. The firm expected changes to the company’s long-term revenue forecast to weigh on the stock. RH — Shares of the home furnishings retailer surged 21% after a stronger-than-expected second quarter. RH reported $1.69 in adjusted earnings per share on $830 million of revenue. Analysts surveyed by LSEG were looking for $1.56 per share on $825 million of revenue. The company’s CEO said in a letter that demand “accelerated” during the quarter and the company expects that to continue into 2025. Adobe — Shares sank more than 8% after the company issued softer-than-expected guidance for the current quarter. Adobe topped fiscal third-quarter estimates on the top and bottom lines. Aptiv PLC — The auto parts stock advanced nearly 3% after CEO Kevin Clark purchased nearly 30,000 shares of Aptiv earlier this week, a filing with the U.S. Securities and Exchange Commission revealed. AstraZeneca — The U.S. listed shares gained 1.5% even after Deutsche Bank downgraded the biopharmaceutical company to sell from hold, citing the disappointing performance of AstraZeneca’s datopotamab deruxtecan drug. Have a happy trading day to everyone in here on this Friday!
